Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

China to allow German expats to use German COVID-19 vaccines

Published 12/09/2022, 11:52 PM
Updated 12/10/2022, 12:00 AM
© Reuters. FILE PHOTO: A nurse displays a vial of the Comirnaty by BioNTech/Pfizer vaccine against the coronavirus disease (COVID-19) at a vaccination centre in Berlin, Germany, January 1, 2022. REUTERS/Michele Tantussi

BEIJING (Reuters) - The Chinese foreign ministry said China and Germany had reached an agreement on providing "German vaccines" to German nationals in China, after the German Chancellor recently said that BioNTech's COVID-19 vaccine would be used by German expatriates.

Relevant arrangements will be discussed and determined by the two sides through diplomatic channels, Mao Ning, a spokeswoman at the Chinese foreign ministry told reporters on Friday at a regular press conference.

© Reuters. FILE PHOTO: A nurse displays a vial of the Comirnaty by BioNTech/Pfizer vaccine against the coronavirus disease (COVID-19) at a vaccination centre in Berlin, Germany, January 1, 2022. REUTERS/Michele Tantussi

On Nov. 4, German Chancellor Olaf Scholz, on his visit to Beijing, announced an agreement to let expatriates in China use the COVID-19 vaccine from Germany's BioNTech.

BioNTech's COVID vaccine would be the first non-Chinese coronavirus vaccine to be administered in China, although to just German nationals, as Beijing had until now insisted on administering domestically produced vaccines.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.